NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Clear Labs

Clear Labs

Private
San Carlos, CaliforniaHealthcare & Life Scienceshttps://www.clearlabs.com/

Last Round

Series D

Jan 13, 2025

Total Funding Raised

$130.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Clear Labs is a biotechnology company that provides a fully automated, end-to-end next-generation sequencing platform for clinical and applied diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

next-generation sequencingNGSmicrobial surveillancepathogen identificationgenomic analysisfood safety testingclinical diagnosticsbioinformatics softwarewhole genome sequencingWGSautomated sequencinglab automationmolecular diagnosticsbacterial detectiongenomic insightssample-to-result

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Clear Labs Comparables

Compare Clear Labs with similar companies based on industry and business-model similarity.

Clear Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EW Group
71%
bioMérieux
67%
Pacific Biosciences of California, Inc.
66%

Clear Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJan 13, 2025
Series CMay 26, 2021
VC RoundMay 14, 2020
Series B ExtensionOct 30, 2018
Series BDec 13, 2016
Series A
Sep 15, 2015

Key People

Founding team and executive leadership

Ramin Khaksar

Chief Operating Officer & Chief Scientific Officer, Co-Founder, Co-Founder

Founding Team

Clear Labs Investors

Notable investors and investment history

Clear Labs investors
InvestorRounds
Redmile GroupSeries C, Series D, VC Round
Counterpoint GlobalSeries D, Series C
GVSeries C, Series B, VC Round, Series D
NimbleVenturesSeries D
Khosla VenturesSeries B Extension, Series C, Series B, VC Round, Series D, Series A
Dentsu VenturesSeries B Extension
HBM Healthcare InvestmentsSeries C, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 14, 2025

    Collaborating with global life sciences company Labcorp.

  • Nov 13, 2025

    Presented new automated workflow at the AMP Annual Meeting.

Clear Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Clear Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Clear Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Carlos, California
Employee Range86
Year Founded2014
Last FundingJan 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.